11016223

Source:http://linkedlifedata.com/resource/pubmed/id/11016223

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006684, umls-concept:C0947611
pubmed:issue	35
pubmed:dateCreated	2000-10-18
pubmed:language	swe
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0027707
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0023-7205
pubmed:author	pubmed-author:LindbergGG, pubmed-author:LindbladUU, pubmed-author:MelanderAA
pubmed:issnType	Print
pubmed:day	30
pubmed:volume	97
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	3714-5
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:11016223-Antihypertensive Agents, pubmed-meshheading:11016223-Calcium Channel Blockers, pubmed-meshheading:11016223-Controlled Clinical Trials as Topic, pubmed-meshheading:11016223-Humans, pubmed-meshheading:11016223-Randomized Controlled Trials as Topic, pubmed-meshheading:11016223-Risk Factors
pubmed:year	2000
pubmed:articleTitle	[A comment on calcium antagonists: what has been elucidated?].
pubmed:affiliation	Samhällsmedicinska institutionen, Malmö.
pubmed:publicationType	Journal Article